Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
HepaRegeniX raised €21.5m from Wellington Partners, Novo Holdings, Boehringer Ingelheim Venture Fund, and Vesalius Biocapital.

HepaRegeniX raised €21.5m from Wellington Partners, Novo Holdings, Boehringer Ingelheim Venture Fund, and Vesalius Biocapital.

Biotech Health services Pharma

Germany

Denmark

Luxembourg

United Kingdom

Investments

04 April 2025

Share:

HepaRegeniX (company)

Germany

Biotech Health services Pharma

Total investments received (USD): 39.35m

Round value (USD): 23.2m

Round investors: Boehringer Ingelheim Venture Fund Novo A/S Vesalius Biocapital Partners Wellington Partners

Company: HepaRegeniX

Industry: Biotech Health services Pharma

Related deals

AMSilk raised €22m in debt and €30m in post series C equity funding led by Athos, joined by insiders MIG Capital and Novo Holdings.

Biotech Health services Manufacturing

Germany

Denmark

Investments 01 September 2025

Aignostics raised $34 million in Series B led by ATHOS, joined by Mayo Clinic, HTGF, Wellington, Boehringer Ingelheim, CARMA Fund, IBB Ventures

AI (big data) Competitive Intelligence Health services Pharma Software Services

Germany

United Kingdom

United States

Investments 20 October 2024

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top